GLP-1RAs, as an important class of drugs for the treatment of T2DM, shows significant advantages in blood glucose control, weight loss, cardiovascular protection and kidney benefit (Ussher and Drucker, 2023
For prescription fills exceeding a 30 day supply, we assumed supply extended across subsequent months (e.g., a 60-day fill was counted as two months of supply)
Eligibility generally includes a body mass index (BMI) of 30 or higher, or a BMI of 27 or higher with a weight-related condition (such as high blood pressure, type 2 diabetes, or abnormal cholesterol)
Interestingly, Hld Se exposure also stimulated the release of another gastrointestinal molecule, serotonin (Fig
Additional regulations None Nebraska Who can prescribe semaglutide